Deployment
Wandercraft Atalante X at New York, USA
Powered, self-balancing full-body lower-limb exoskeleton that walks HANDS-FREE (no crutches) using AI-driven dynamic balance across ~12 actuated degrees of freedom. The autonomy is real-time balance/gait control; clinician sets the session. FDA cleared early 2024, indications expanded 2025 (MS, C4-L5 SCI). Deployed in 100+ rehab/research facilities.
Wandercraft Atalante X by Wandercraft · Catalog entry · 1 source · not yet field-verified · Exoskeletons
Recent coverage
- First patient enrolls in clinical trial for Wandercraft Atalante X exoskeleton - The Robot ReportGoogle News · 2026-01-30
- Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss - BioSpaceGoogle News · 2025-11-04
- FDA expands indications for Wandercraft robotic exoskeleton - MassDeviceGoogle News · 2025-11-03
Wandercraft Personal Exoskeleton — first self-balancing personal exoskeleton that doesn't require crutches. Clinical trials launched in the United States. FDA-cleared Atalante X for rehab centers in Europe, US, and Brazil.
Exposure
- Customer segment
- healthcare
Each exposure value carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Safety record
No incidents on record for Wandercraft Atalante X at New York, USA.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
- Trust tier
- Catalog entry · 1 source · not yet field-verifiedhow tiers work →
- Last updated
- 2026-08-09
- Company
- Wandercraft
- Location
- New York, USA
- Operator
- Wandercraft
- Status
- operational
- Operator type
- maker operated
- Scale at site
- clinical
- Site environment
- clinical
- First seen
- 2024-01-01
- ID
2ce2a2f6-100c-4bbb-bab1-7e958f864d9b
Timeline
- Jan 2024First recordedWandercraft Atalante X first documented operating at New York, USA.
- Aug 2026Current status: operational, reviewedLatest recorded state. New status transitions append here as the deployment-status recorder produces them.
On the deployment map
Wandercraft Atalante X operates in New York, USA. Explore the full verified map:
Sources (1)
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-09
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-09
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: exoskeleton
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Wandercraft Atalante X at New York, USA.Common questions
What is the Wandercraft Atalante X deployment at New York, USA?
Who operates Wandercraft Atalante X at New York, USA?
When did the Wandercraft Atalante X deployment at New York, USA go live?
Have there been incidents at the Wandercraft Atalante X deployment at New York, USA?
Deploy Watch
Track this deployment.
We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.
Machine-readable surfaces
- Markdown mirror: /deployments/wandercraft-personal-clinical-trial.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/robots/2ce2a2f6-100c-4bbb-bab1-7e958f864d9b
- Data documentation: /data
- Query this programmatically: Deploy MCP